Cohort for Monitoring Patients With Venous Thromboembolic Disease

Recruiting now

Conditions studied: Venous Thromboembolic Disease

In brief

Venous thromboembolic disease is a common pathology in the general population (1.5/1000), the prognosis of which depends in particular on the risk of recurrence. This risk depends essentially on whether the thrombotic episode was provoked or not. Thus, patients who present a thromboembolic event without any contributing factor have a high risk of recurrence, which encourages clinicians to continue anticoagulant treatment for a long time. However, anticoagulant treatment is the leading cause of hospitalization for iatrogenic causes and the leading cause of iatrogenic mortality. The benefit-risk balance of treatment must be evaluated regularly, which requires a good knowledge of the risk factors for thrombotic recurrence and the risk factors for hemorrhage.

Key facts

Study ID: NCT07016542
Run by: University Hospital, Rouen
People needed: 2000
Starts: 2019-11-18
Expected to finish: 2032-06-01
Last updated by the study team: 2025-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Any patient over 18 years of age who has experienced at least one venous thromboembolic episode:
Deep vein thrombosis confirmed by Doppler ultrasound or CT venography,
Pulmonary embolism confirmed by CT angiography, ventilation/perfusion scan, or confirmed DVT episode with respiratory signs consistent with PE.
Hospitalization in the Internal Medicine Department
Consultation by an Internal Medicine physician
File presented at the thrombosis multidisciplinary meeting

You may not qualify if…

Thrombosis not meeting the inclusion criteria (cerebral venous thrombosis, mesenteric)

Where it is running

University Hospital of Rouen — Rouen, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.